These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

129 related items for PubMed ID: 30904

  • 1. QSAR of agents involved in serotonin and LSD binding sites.
    Chan YL, Lien EJ, Shih JC.
    NIDA Res Monogr; 1978; (22):103-13. PubMed ID: 30904
    [No Abstract] [Full Text] [Related]

  • 2. 5-Methoxytryptamine: stimulation of 5-HT receptors mediating the rat hyperactivity syndrome and blood platelet aggregation.
    Boullin DJ, Green AR.
    Adv Biochem Psychopharmacol; 1976; 15():127-40. PubMed ID: 15408
    [No Abstract] [Full Text] [Related]

  • 3. A common mechanism for lysergic acid, indolealkylamine and phenethylamine hallucinogens: serotonergic medication of behavioral effects in rats.
    Sloviter RS, Drust EG, Damiano BP, Connor JD.
    J Pharmacol Exp Ther; 1980 Aug; 214(2):231-8. PubMed ID: 6104720
    [No Abstract] [Full Text] [Related]

  • 4. Behavioral evidence for the stimulation of CNS serotonin receptors by high doses of LSD.
    Trulson ME, Ross CA, Jacobs BL.
    Psychopharmacol Commun; 1976 Aug; 2(2):149-64. PubMed ID: 136010
    [Abstract] [Full Text] [Related]

  • 5. Displacement of specific serotonin and lysergic acid diethylamide binding by Ergalgin, a new antiserotonin drug.
    Oelszner W.
    Acta Biol Med Ger; 1980 Aug; 39(8-9):897-901. PubMed ID: 7282219
    [Abstract] [Full Text] [Related]

  • 6. Serotonin and lysergic acid diethylamide binding in rat brain membranes: relationship to postsynaptic serotonin receptors.
    Bennett JP, Snyder SH.
    Mol Pharmacol; 1976 May; 12(3):373-89. PubMed ID: 6896
    [No Abstract] [Full Text] [Related]

  • 7. Recognition and activation mechanisms on the LSD/serotonin receptor: the molecular basis of structure activity relationships.
    Weinstein H, Green JP, Osman R, Edwards WD.
    NIDA Res Monogr; 1978 May; (22):333-58. PubMed ID: 101884
    [No Abstract] [Full Text] [Related]

  • 8. 5-HT and LSD high affinity binding sites to brain synaptosomal membranes [proceedings].
    Fillion G, Fillion MP, Jacob J, Rousselle JC.
    Br J Pharmacol; 1976 Nov; 58(3):425P-426P. PubMed ID: 990612
    [No Abstract] [Full Text] [Related]

  • 9. Unsurmountable antagonism of brain 5-hydroxytryptamine2 receptors by (+)-lysergic acid diethylamide and bromo-lysergic acid diethylamide.
    Burris KD, Sanders-Bush E.
    Mol Pharmacol; 1992 Nov; 42(5):826-30. PubMed ID: 1359397
    [Abstract] [Full Text] [Related]

  • 10. Dual actions of lysergic acid diethylamide tartrate (LSD), 2-bromo-D-lysergic acid diethylamide bitartrate (BOL) and methysergide on dorsal root potentials evoked by stimulation of raphe nuclei.
    Larson AA, Chinn C, Proudfit HK, Anderson EG.
    J Pharmacol Exp Ther; 1981 Apr; 217(1):99-104. PubMed ID: 6110778
    [Abstract] [Full Text] [Related]

  • 11. Stereospecific receptor sites for d-lysergic acid diethylamide in rat brain: effects of neurotransmitters, amine antagonists, and other psychotropic drugs.
    Lovell RA, Freedman DX.
    Mol Pharmacol; 1976 Jul; 12(4):620-30. PubMed ID: 8700
    [No Abstract] [Full Text] [Related]

  • 12. (+)Lysergic acid diethylamide, but not its nonhallucinogenic congeners, is a potent serotonin 5HT1C receptor agonist.
    Burris KD, Breeding M, Sanders-Bush E.
    J Pharmacol Exp Ther; 1991 Sep; 258(3):891-6. PubMed ID: 1679849
    [Abstract] [Full Text] [Related]

  • 13. Actions of D-lysergic acid diethylamide (LSD) and its derivatives on 5-hydroxytryptamine receptors in the isolated uterine smooth muscle of the rat.
    Hashimoto H, Hayashi M, Nakahara Y, Niwaguchi T, Ishii H.
    Eur J Pharmacol; 1977 Oct 15; 45(4):341-8. PubMed ID: 923645
    [No Abstract] [Full Text] [Related]

  • 14. Serotonin receptors in the brain.
    Haigler HJ, Aghajanian GK.
    Fed Proc; 1977 Jul 15; 36(8):2159-64. PubMed ID: 326580
    [No Abstract] [Full Text] [Related]

  • 15. [3H]WB4101 labels the 5-HT1A serotonin receptor subtype in rat brain. Guanine nucleotide and divalent cation sensitivity.
    Norman AB, Battaglia G, Creese I.
    Mol Pharmacol; 1985 Dec 15; 28(6):487-94. PubMed ID: 2867462
    [Abstract] [Full Text] [Related]

  • 16. Pharmacological characterization of 3H-LSD binding sites in mouse brain in vivo.
    Duchemin AM, Quach TT, Rose C, Schwartz JC.
    Life Sci; 1979 Jan 29; 24(5):401-9. PubMed ID: 431327
    [No Abstract] [Full Text] [Related]

  • 17. LSD, 5-HT (serotonin), and the evolution of a behavioral assay.
    Appel JB, West WB, Buggy J.
    Neurosci Biobehav Rev; 2004 Jan 29; 27(8):693-701. PubMed ID: 15019419
    [Abstract] [Full Text] [Related]

  • 18. Characterisation of [3H]lysergic acid diethylamide binding to a 5-hydroxytryptamine receptor on human platelet membranes.
    Geaney DP, Schächter M, Elliot JM, Grahame-Smith DG.
    Eur J Pharmacol; 1984 Jan 13; 97(1-2):87-93. PubMed ID: 6698111
    [Abstract] [Full Text] [Related]

  • 19. Citalopram antagonizes the stimulation by lysergic acid diethylamide of presynaptic inhibitory serotonin autoreceptors in the rat hypothalamus.
    Langer SZ, Moret C.
    J Pharmacol Exp Ther; 1982 Jul 13; 222(1):220-6. PubMed ID: 6953233
    [Abstract] [Full Text] [Related]

  • 20. Stereoselective pharmacological effects of lysergic acid amides possessing chirality in the amide substituent.
    Nichols DE, Monte A, Huang X, Marona-Lewicka D.
    Behav Brain Res; 1996 Jul 13; 73(1-2):117-9. PubMed ID: 8788487
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.